New Clinical Trial to Study the Use of MYOBLOC Injections into the Salivary Glands to Treat Sialorrhea

20-11-2013 Business Wire HealthComments (0)

MyoblocPharmaceutical

US WorldMeds has launched a Phase 3 clinical trial to investigate the use of MYOBLOC (rimabotulinumtoxinB) Injection for sialorrhea, commonly known as drooling.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top